We need answer. Need be careful. Need solve merger screen. Need produce final with calculations. Need adhere. Let's parse. Need analyze industrial conductive yarn market shares: Alder 12, Prism 8, combined 20%. Premerger HHI: Need sum squares shares: 12^2=144 8^2=64 25^2=625 20^2=400 15^2=225 10^2=100 10^2=100 Sum? 144+64=208; +625=833; +400=1233; +225=1458; +100=1558; +100=1658. Pre HHI 1658. Postmerger combined 20%, HHI increase = 2*12*8 = 192. Post HHI = 1658 + 192 = 1850? Let's check sum squares with shares [20,25,20,15,10,10] squares =400+625+400+225+100+100=1850. Yes. Filing triggers: threshold above $100m yes? size? Transaction $140m >100m; Need in any properly defined market either combined share at least 25 or postmerger HHI >1800 and increase >200. Industrial yarn: combined 20 <25, post HHI 1850 >1800 but increase 192 not >200. So neither trigger. Structural presumption requires post>1800 and increase >200; not applies because increase not >200. But may still investigation? Need mention maybe post HHI high but delta not enough for presumption; no filing trigger from this market. Medical conductive mesh: Verified domestic revenue totals $80m includes Alder 18, Prism 6, others 56. Combined revenue 24. Market share as verified domestic only (assuming no qualifying imports) = 24/80 = 30%. Let I = qualifying import revenue, 0 ≤ I ≤ 30. Denominator = 80 + I. Combined share =24/(80+I). Need find I where combined share falls below 25%. Solve 24/(80+I) < 0.25. At 25% denominator=96 => I=16. If I >16, share below 25%. Equal at 16 exactly: 24/96=25%. Trigger requires at least 25%, if exactly 25 qualifies "at least 25 percent", so need I >16 to fall below. If imports 16 exactly share 25 -> filing trigger (assuming other trigger? Actually combined share at least 25 and transaction >100; yes) So threshold: if qualifying imports revenue is ≥? If I = $16m, share 25%; requirement for no filing based on share is imports "more than 16" not "at least 16." Formula: share =24/(80+I); below 25 iff 80+I >96 => I>16. If I=16, not below, trigger. If no import data, plausible range includes below/at/above. But note problem says "If qualifying imports exist, add them to $80 million market denominator. No verified seller-by-seller import shares available, so reliable HHI cannot yet be calculated." Combined share formula. Need exact level 16 million. More nuanced: imported revenue added to denominator but not attributed to Alder/Prism; assumes imports are by other sellers. If Alder/Prism maybe also sell imports? They state Alder and Prism combined medical-mesh revenue is complete; if additional imports exist, add denominator. If no seller-by-seller import shares available, HHI cannot calculate. However maybe market shares for HHI excluding imports? Need discuss. Need analyze filing for medical market under rules: Transaction >$100m. If combined share at least 25 in properly defined market. Medical combined share with only verified $80m =30% >25 => trigger; postmerger HHI? Cannot calculate because import shares missing. But if no verified imports, HHI maybe based on market: Alder share 22.5%, Prism 7.5%, others combined 70% but HHI cannot compute from "others combined" unless seller shares of other verified sellers known. The facts only say "Other verified sellers combined: $56 million" no individual shares. Could maybe if imports absent and only combined other, cannot calculate reliable HHI either? But combined share can be calculated because numerator and denominator known. Need mention HHI cannot yet be calculated because (i) no verified seller-by-seller import shares; (ii) even within remaining $56 million, no individual shares of "other verified sellers" are supplied. Actually if other verified sellers combined, not enough to calculate HHI. If all imports are other sellers, need shares of each seller including importers to calculate HHI. We can state with current data, HHI for medical mesh cannot be reliably calculated due to incomplete seller-level shares; additional imports are not allocated. This also matters under structural presumption but filing already triggered by share. Need answer "Whether either filing trigger or structural presumption applies in that market." In industrial market? Neither. In medical? Filing trigger applies based on 30% share absent imports? If imports >16? Need not? But record unverified and range. Filing obligation is based on actual facts? We can recommend conservative. There is already verified domestic market: combined share 30%. The rule says claimed imports included only to extent verified. Additional unverified imports cannot reduce current verified share for filing? Hmm important. Existing facts: "Verified domestic-market revenue totals $80 million and includes..." So there are verified domestic sales. Additional imported mesh is claimed, not verified. Rule 3: Revenue from products delivered into market counts regardless; claimed imports included only to extent verified as sales into market during measurement year. Since additional imports not verified, at this moment in record, combined share =24/80=30%, trigger. But if after verification qualifying imports >16, combined share <25; but if not verified, can't count. Does that mean must file now? Need think. The "parties want to sign next week and close in 35 days. Management argues no filing needed because imports probably push us below 25 percent." Governing law says when known, obtainable market input determines filing, counsel must obtain it or recommend filing conservatively. It may not assume input in direction preferred by client. The specialist can verify within ten days. So because qualifying import revenue is obtainable and determines filing, must obtain it before concluding no filing; if can't obtain before next week, recommend filing conservatively or schedule? There's nuance: It can verify within 10 days; parties want to sign next week and close in 35 days. If waiting ten days is feasible before closing? Signing next week not closing; but filing should be before closing. But premerger filing often before closing, maybe after signing. If wait 10 days to get import verification, likely still before close (35 days). Could wait for data before deciding? Need "file now, wait for ten-day data work, or proceed without filing, with concrete recommendation conditioned on missing market figure." Need determine. The assignment asks: - Combined share, premerger HHI, postmerger HHI, HHI increase for industrial yarn. - Whether either filing trigger or structural presumption applies in that market. - Medical-mesh combined-share formula using qualifying import revenue. - Exact import-revenue level at which combined share falls below 25 percent. - Why medical-mesh HHI cannot yet be calculated reliably. - Specific data needed to verify imports. - Filing and gun-jumping consequences. - Whether to file now, wait for ten-day data work, or proceed without filing, with concrete recommendation conditioned on missing market figure. Need produce final. Let's unpack legal and factual details: Governing law: 1. Premerger filing required for transaction above $100 million when, in any properly defined market, either (a) parties' combined share at least 25%; or (b) postmerger HHI exceeds 1,800 and merger increases HHI by more than 200 points. 2. HHI sum of squared shares. Combining firms increases HHI by twice product. 3. Revenue delivered into market counts regardless seller location. Claimed imports included only to extent verified as sales into relevant market during measurement year. 4. Post HHI >1800 and increase >200 creates structural presumption. Other screens don't create presumption but may still require investigation. 5. Product-market definition customer substitution; distinct products not combined. 6. Must file before closing when threshold met. Closing without required filing exposes each party to $40,000 per day from closing until compliance. 7. When a known, obtainable market input determines filing, counsel must obtain it or recommend filing conservatively. It may not assume input in direction preferred by client. 8. Filing not concede illegality. Facts: Two products separate: industrial yarn and medical mesh. Industrial shares sum 100. Medical verified domestic total $80m: Alder $18m, Prism $6m, others $56m. Industry participants report additional imported mesh, not established delivery. Customs codes combine medical mesh with unrelated textiles. Specialist can verify qualifying import revenue within 10 days from customer/importer records. Plausible unverified range $0 to $30m. Alder/Prism combined $24m complete. If qualifying imports exist, add to $80m denominator. No verified seller-by-seller import shares, reliable HHI cannot yet be calculated. Parties sign next week close in 35 days. Management says no filing because imports probably push below 25%. Need maybe mention "properly defined market" and "industrial conductive yarn" is separate due to customer substitution; medical mesh separate. Need exact import level: Let Q = verified qualifying import revenue in $m. Denom = 80 + Q. Combined share = 24/(80+Q) (assuming no imports attributable to Alder/Prism; since their revenue complete? The phrase "Assume Alder and Prism's $24 million combined medical-mesh revenue is complete. If qualifying imports exist, add them to the $80 million market denominator. No verified seller-by-seller import shares are available" This indicates all imports are additional sellers, not Alder/Prism; yes formula.) Share <25% iff: 24/(80+Q) < 0.25 24 < 0.25(80+Q)=20+0.25Q 4 <0.25Q 16 < Q. At Q=16, share=25. So no-filing on share trigger requires verified imports >$16m. If Q=16, 25%, not below. Since trigger at at least 25, still file if exactly 16. If Q>16, share <25 and if HHI not trigger? Need medical HHI not calculable but likely? Let's examine: If qualifying imports >16, combined share below 25. But filing trigger can still be met if post HHI >1800 and increase >200 in medical market, based on shares after adding imports. But HHI cannot be reliably calculated due to lack seller-level data. Is it possible to determine HHI lower/upper bounds? Maybe with only combined other sellers, HHI unknown. But if combined share below 25, and market likely concentrated? We don't know. Need not assume. But for filing, if share trigger not met, need HHI to determine. The problem says no verified seller-by-seller import shares; reliable HHI cannot yet be calculated. Thus cannot rule out filing on HHI basis. But maybe they only ask whether either filing trigger or structural presumption applies in industrial market, not medical. For medical, "filing trigger" maybe combined share. Hmm. Need mention if imports verified >16, share trigger disappears, but HHI trigger might still be possible (or impossible to tell) because HHI cannot be calculated. Yet if no individual seller shares, maybe we know post-HHI? Let's see if all import revenue added as individual sellers absent maybe HHI lower? Need derive bounds with total revenue and combined merging share? Maybe possible to determine maximum/minimum HHI? The instruction specifically says "No verified seller-by-seller import shares are available, so a reliable medical-mesh HHI cannot yet be calculated." So we shouldn't calculate HHI. But maybe one can compute worst-case: Given only combined share = s, HHI increase from merger = 2*a*b in share units (a=18/(80+Q), b=6/(80+Q)). But HHI base includes unknown distribution of remaining revenue and imports. Cannot know postmerger HHI. The HHI increase itself can be calculated if combined share? Actually HHI increase = 2 * AlderShare * PrismShare. If Alder's revenue =18, Prism=6, denominator =80+Q. With no imports attributed to merging parties, Alder share=18/(80+Q), Prism=6/(80+Q). Increase=2*18*6/(80+Q)^2? Wait if shares as percentages expressed as 0-100: 2 * (18/D*100) * (6/D*100) = 21600/D^2? But if share as decimal, 2*18/D*6/D. In HHI points, using percent shares, delta = 2 * a% * b% = 2 * (1800/D) * (600/D)? Let's compute: D in millions. Alder share % = 1800/D? No 18/D*100 = 1800/D. Prism share = 600/D. Delta = 2*(1800/D)*(600/D)=2,160,000 / D^2? Let's test D=80: A=22.5%, P=7.5%, delta=2*22.5*7.5=337.5. 2,160,000 /6400=337.5. Yes. Postmerger combined share = 2400/D %. Hmm. So delta can be calculated if Q known and no merging-party imports, but pre/post HHI need other shares. If imports not allocated by seller, HHI base unknown; but delta known. To evaluate trigger (post HHI >1800 and delta >200) at Q large? As Q increases, A and P shares drop, delta drops. For Q=30, D=110, A=16.36, P=5.45, delta=178.5 <200. So if Q≥? delta <=200 when 2,160,000/D^2 <=200 => D^2 >=10800 => D >=103.923 => Q >=23.923. At max Q=30 delta not >200. For no verified imports Q=0, delta=337.5 >200. But post HHI unknown. The share trigger at Q<=16; at Q=16 trigger share=25. For Q in 16-23.9, share less than25 but delta>200. Could HHI trigger if post HHI >1800? Need know concentration. With remaining 56m domestic "other combined" maybe could be many firms; if imports include many firms, HHI might be below 1800. But if a few competitors, above. Cannot know. Need not speculate. The HHI increase threshold may be >200 until Q just under $23.9m. This is a useful nuance. But the problem says "No verified seller-by-seller import shares are available, so a reliable medical-mesh HHI cannot yet be calculated." But "HHI increase" can be calculated from combining shares and no imports allocated to merging parties, assuming Alder/Prism don't import. But HHI trigger requires postmerger HHI >1800; not calculable absent seller-by-seller. Should we mention delta as additional missing issue? Yes, maybe. Need read exact facts: "Assume Alder and Prism's $24 million combined medical-mesh revenue is complete. If qualifying imports exist, add them to the $80 million market denominator. No verified seller-by-seller import shares are available, so a reliable medical-mesh HHI cannot yet be calculated." It says HHI cannot yet be calculated because no verified seller-by-seller import shares. But if there are no imports, no import shares; still "other verified sellers combined $56 million" no individual. Maybe also not enough. Perhaps they expect "HHI cannot be calculated because imports would alter shares of all participants. Need identify individual import sellers and revenue, not aggregate." Good. Need compute premerger HHI industrial: Premerger HHI 1658. Post HHI 1850. Increase 192. Combined share 20%. No filing threshold from industrial: combined share less than25; post HHI above1800 but increase not above200. Structural presumption? post>1800 but increase not >200, so no. Medical filing: As verified (Q=0 currently), denominator $80m, combined share 30%. Transaction >$100m. Because combined share at least25, filing required if closing before data? Yes. Under Rule 7, cannot rely on unverified imports. Unless and until qualifying imports are verified and exceed $16m, share remains 30%? Let's be precise: If after verification, we may learn actual Q. But if the verification hasn't occurred, the only "verified" market is $80m. Claimed imports are not included. Thus current record supports filing. The rule says "claimed imports are included only to extent verified as sales." So yes, at this point, no verified imports, trigger met. But maybe "industry participants report additional imported mesh" are facts? The supplied record does not establish how much was actually delivered. They are claimed; not verified. So not included. Need calculate "medical-mesh combined-share formula using qualifying import revenue." Use I. Let I = verified import revenue ($m) into Corda in measurement year. Market size = 80 + I. Alder+Prism combined revenue = 24. Combined share = 24/(80+I) ×100. They ask "Exact import-revenue level at which combined share falls below 25 percent." I > $16m. Note if I=16, share exactly 25; "falls below" requires >16. Need "specific data needed to verify imports." Need from customer and importer records: - Identity of importers/sellers (who sold medical conductive mesh into Corda). - Customer identities and delivery destination (delivered into Corda) during measurement year. - Product description/classification matching medical conductive mesh, not broader customs code; exclude unrelated textile products. - Sales volumes and revenue in dollars during relevant measurement year; perhaps invoices, shipping documents, customs entries, bills of lading, proof of delivery. - Whether imports were resold/delivered in Corda vs transshipped or delivered elsewhere. - Maybe timing: delivered during measurement year, regardless seller location. - Need seller-by-seller allocation to compute HHI, not just total qualifying import revenue. - Need possibly verify no double counting with domestic revenue: if imports sold by "other verified sellers" maybe included? Rule says revenue from delivered products counts. Need all relevant sales. Need avoid combining customs code medical mesh with unrelated textile. Need "Filing and gun-jumping consequences." Discuss: - If required and not file before closing: penalties $40,000 per day per party? Wording "exposes each party to $40,000 per day from closing until compliance." So combined up to $80,000/day? It says each party; need state each party may be liable $40k/day. "Closing without required filing" likely each party. Need not overstate. Must file before closing, not necessarily before signing. Signing next week okay; close in 35 days but need clearance/waiting period perhaps. If sign before filing, no gun-jumping if no coordination/operational control before closing and subject to antitrust rules? Gun-jumping generally can occur even with filing if parties coordinate; "filing and gun-jumping consequences" maybe mention: The requirement is to file before closing, but if you wait and close before obtaining data/clearance? Also "gun-jumping" means closing without required filing (or coordinating before clearance) can expose penalties. Need mention not to exchange competitively sensitive information/operate as merged before closing; but issue primarily filing timing. Let's parse wording: "Closing without a required filing exposes each party to $40,000 per day from closing until compliance." They call "gun-jumping consequences." Need say: if trigger is met, closing before filing/Hart-Scott-Rodino? Actually Corda rules require file before closing, no waiting period? Let's read: "Parties must file before closing when a threshold is met. Closing without a required filing exposes each party to $40,000 per day from closing until compliance." No specified waiting period; but maybe need wait until antitrust review completes? It says "Governing law: ... A premerger filing is required ... Closing without required filing exposes..." Could imply file prior to closing, maybe no waiting period specified. But "closing without required filing" is the gun-jumping. We should avoid inventing waiting period if not stated. Maybe state at minimum, under the facts, do not close until any required filing is made; penalties run until compliance. Signing alone does not trigger filing unless thresholds known? Actually requirement triggered by transaction; must file before closing. Need not file before signing, but if signing next week and no data, conservative file soon. If after data no longer threshold, if filed unnecessarily can withdraw? Maybe mention filing not concession; but could file now if in doubt. But under Rule 7 if input obtainable, "counsel must obtain it or recommend filing conservatively." Need choose. Need "Whether to file now, wait for ten-day data work, or proceed without filing, with a concrete recommendation conditioned on missing market figure." Need decide final recommendation. likely: - Do not proceed without filing on management's "probably" theory; that violates Rule 7. - The ten-day verification is feasible before close (35 days). So instruct specialists to obtain and verify qualifying import data now. - Current verified record already triggers filing. If the verification is expected within 10 days and before close, can we wait to decide? Rule 7 says must obtain it OR recommend filing conservatively. If can obtain in 10 days and close in 35, maybe may wait 10 days to obtain actual data before filing? Need think. But "A premerger filing is required above $100m when, in any properly defined market..." The "when" maybe determined at signing? Actually at time before closing; if data not verified, cannot establish imports. It might be okay to wait until data verified as long as file before closing. But the rule says "When a known, obtainable market input determines filing, counsel must obtain it or recommend filing conservatively. It may not assume the input in direction preferred by client." We need maybe say obtain it; if it can be obtained within 10 days, wait only if you can ensure result before any signing/filing? But signing next week may happen before data. Does signing create obligation? Let's reason with HSR-like: filing required before closing, not before signing. If a transaction is above threshold and share threshold based on current facts, should file before signing? Usually HSR filing can be after signing, before closing. The problem didn't say signing triggers. Could wait ten days post-signing before deciding? But management wants sign next week and close in 35. If you wait 10 days, still 25 days before close. If data shows filing needed, you can file before close. Unless Corda has waiting period not stated; no. So a conditional recommendation: Start 10-day verification immediately. Do not proceed without a verified result. If by (say) day 10 the verified import revenue >$16m, and HHI trigger cannot be excluded? Need continue? Wait if share below 25 but HHI missing; you still need seller-by-seller import shares to determine HHI. The 10-day data "can verify qualifying import revenue" but "No verified seller-by-seller import shares are available" maybe specialist can verify from customer and importer records perhaps also seller-by-seller. "specific data needed to verify imports" includes seller-by-seller, to compute HHI. Need perhaps after ten days, you may get total qualifying import revenue and seller-by-seller allocations? Question says "specialist can verify qualifying import revenue within ten days from customer and importer records." It doesn't say can verify seller-by-seller shares? But to compute HHI, need seller-by-seller. Maybe "qualifying import revenue" total is enough for share; but HHI requires seller-by-seller; maybe from records could also identify import sellers. Need recommend obtain seller-by-seller shares too if needed. Need answer to "Whether to file now, wait for the ten-day data work, or proceed without filing, with a concrete recommendation conditioned on the missing market figure." The phrasing "concrete recommendation conditioned on the missing market figure" means: - If verified imports >16m: combined share <25; but HHI still unknown. Need obtain seller-level data to see HHI trigger. If reliable HHI can be calculated and doesn't hit trigger, no filing likely; if not available, conservative file. - If verified imports ≤16m (including no imports): combined share ≥25; must file before closing. Maybe they want "file now" because current verified record already 30%, and cannot wait because filing before close? Let's explore. Potential nuance: "Assume Alder and Prism's $24 million combined medical-mesh revenue is complete. If qualifying imports exist, add them to the $80 million market denominator." They ask "exact import-revenue level at which the combined share falls below 25 percent." Then "Parties want sign next week and close in 35 days. Management argues no filing is needed because imports probably push us below 25 percent." Under rule 7, "When a known, obtainable market input determines filing, counsel must obtain it or recommend filing conservatively. It may not assume the input in the direction preferred by client." So answer should probably: Management's "probably" justifies neither no filing nor wait; must verify or file. Since verification possible within 10 days and closing 35 days away, instruct verification; if verified imports exceed 16m and HHI can be calculated? But "the supplied record does not establish how much imported; specialist can verify ... within ten days." It might be better to not wait to file because file now is conservative and filing doesn't concede; but if data after 10 days shows no filing, filing may be unnecessary. Under rule 7, if "known, obtainable market input determines filing, counsel must obtain it or recommend filing conservatively." It doesn't require file before obtaining; it says obtain it or recommend filing conservatively. Since obtainable in 10 days and close in 35, likely wait and obtain, not file now? But if already current verified share 30%, is market input "obtainable" or "known"? Current verified imports zero? Actually "claimed imports not verified"; there is "plausible unverified range"; specialist can verify. Rule 3 says imports included only to extent verified. So today's verified market has no additional imports. Is that a "known, obtainable market input determines filing"? Yes, import revenue is known to be obtainable. But if current record already triggers, do we have an obligation to file before closing? If data may disprove trigger, perhaps no need if obtained before closing. If data confirms trigger, file before closing. But if signing next week, after signing you might close before data? no, 35 days. Need maybe recommend "file now to be safe" due to penalties and because currently share 30; but if you wait 10 days and still file, no risk as long as before closing. It might reduce unnecessary filing. Rule 8 says filing doesn't concede, so conservative filing is acceptable. Which is more appropriate? Need infer from assignment: "Whether to file now, wait for the ten-day data work, or proceed without filing, with a concrete recommendation conditioned on the missing market figure." This suggests answer should weigh options. "File now" if trigger met on existing verified record. But "wait for data work" might be acceptable because closing in 35 days and verification in 10 days, and known obtainable input can be obtained. Yet if current verified record has 30%, the required "when threshold is met" is based on facts after considering verified imports. But because imports not verified yet, we cannot include them. If closing today, filing required. But if you are not closing for 35 days and can get data, could wait. The problem says "A premerger filing is required for a transaction above $100 million when, in any properly defined market, either..." It doesn't state when measured: at signing or closing? It may mean at time of filing/transaction. If threshold currently met based on verified data, required. But additional imports can be verified later and retroactively? Hmm. Need think like antitrust counsel. Suppose HSR: You must determine "as of date of closing" or "date of filing"? HSR size-of-market share is based on "annual net sales" or "value of assets" in relevant market? Actually HSR requires if voting securities/assets: size-of-person and size-of-transaction; there are no share thresholds except for certain "entitlement" maybe? This is fictional. In EU merger control, turnover thresholds no market share. But here market share thresholds. For premerger notification, share tests measured at time of "agreement" maybe? But question likely expects use of current record; if threshold currently met, file. However management wants sign next week and close in 35; specialist can verify within 10 days. If no filing and data disproves, okay if before closing? But if not file before close, penalties. I think recommend: Start verification immediately; if the verification cannot be completed before signing? Even if data comes after signing but before closing, okay. But if management is unwilling to wait? Hmm. Let's parse "The parties want to sign next week and close in 35 days. Management argues no filing is needed because 'imports probably push us below 25 percent.'" They ask "Whether to file now, wait for the ten-day data work, or proceed without filing, with a concrete recommendation conditioned on the missing market figure." They probably want: Given Rule 7, file now or get data; don't rely on "probably"; but perhaps "wait for data work" is allowed if data can be obtained within 10 days and closing isn't for 35 days. Yet "file now" is the safest; "without filing" is unacceptable. Need maybe recommend conditional: - Do not rely on management's unverified estimate. - Obtain the 10-day import verification immediately. - File now if the verified import threshold is not established before signing or if any delay risks close. If the verified import total is >$16m and seller-by-seller data permits reliable HHI below thresholds? Wait if share below 25, HHI maybe still cannot calculate. Need condition. Let's inspect exact wording "specialist can verify qualifying import revenue within ten days from customer and importer records." It says "qualifying import revenue" singular total. "No verified seller-by-seller import shares are available, so a reliable medical-mesh HHI cannot yet be calculated." If after ten days we can get qualifying import revenue total but not seller-by-seller import shares, HHI remains unknown. But perhaps if total qualifying imports >16, no share trigger. Does HHI trigger maybe impossible? No, if imports are fragmented? Need know HHI. Can we compute possible upper/lower bounds with given info? Maybe perhaps the problem's "No verified seller-by-seller import shares" means we cannot calculate "reliable HHI" but maybe we can determine HHI trigger? Let's see if we can bound HHI with total market size and combined revenues, maybe enough? Let's explore. Market shares percentages: A = 1800/D, P = 600/D, combined C = 2400/D. Residual share R = 100 - C = (100D - 2400)/D? Actually other revenue = D -24 million. Other share = (D-24)/D ×100 = 100 - 2400/D? Wait A+P share percent = 2400/D (D in millions). For D=80, combined=30; other share=70. For D=110, combined=21.818; other=78.182. HHI increase = 2160000/D^2? Let's recompute with D in $m and shares percent: A = (18/D)*100 = 1800/D. P = (6/D)*100 = 600/D. Delta = 2AP = 2*(1800/D)*(600/D) = 2,160,000 / D^2. Wait for D=80: 2,160,000/6,400 = 337.5. Yes. If D=96: delta = 2,160,000/9,216 = 234.375 (share A=18.75, P=6.25, delta=234.375). At D=104: 2,160,000/10,816 = 199.7? Let's calculate threshold D^2=10,800 => D=103.923, so at D=104 delta ~199.7. Good. Post HHI = preHHI + delta. Need preHHI includes other shares. Without knowing distribution, preHHI minimum given other share R? For fixed market shares of merging parties and residual R, HHI can range. Minimum HHI when residual is infinitely fragmented approaches (A^2+P^2) (0 for residual). But with finite number? Max = A^2+P^2+R^2 if all other revenue in one seller (plus maybe R^2) = A^2+P^2+(100-C)^2. Need know if max >1800. Let's compute at D=110: A=16.36, P=5.45, other=78.18. Max HHI = A^2+P^2+R^2 = 267.8+29.8+6112 = 6410 >1800. But HHI trigger requires actual, not worst case. Minimum at D=110 if many small others = A^2+P^2 ≈ 297.6, post with delta maybe 476 <1800. So cannot know. At D around? For no imports D=80, A=22.5, P=7.5, residual=70. Min HHI approx 506+? With no residual? Actually A^2+P^2=562.5; residual fragmented min 0; post max maybe 337; still min 900. HHI trigger may or may not. But share trigger already. Need maybe include "Even if total qualifying imports exceed $16 million, a reliable HHI is necessary for the second trigger; without seller-by-seller shares, do not assume HHI is safe. If HHI cannot be verified before close, file conservatively." That's important. Need think about "structural presumption" for medical? If filing on share trigger no structural presumption? Let's compute? Since HHI unknown, cannot determine structural presumption. The rule says post HHI >1800 and increase >200 creates structural presumption. We cannot apply because HHI unknown. If share trigger already applies, structural presumption is separate. Need mention. Need maybe discuss "combined share formula" if imports are not attributed to Alder/Prism. If imports could include Alder/Prism sales? The fact says Alder and Prism's combined revenue complete; if qualifying imports exist, add to denominator. That suggests imports are additional market revenue by others. If any qualifying imports would also be included in Alder/Prism's "complete revenue," then formula denominator may still be right but numerator includes any of their import sales; not double count. But we can state: assuming the $24m includes all Alder/Prism medical mesh delivered into Corda (domestic or imported), numerator is 24; denominator is 80+I. If imported revenue includes sales by Alder/Prism beyond $24m, numerator would be higher; not fact. Need mention because "Assume Alder and Prism's combined revenue is complete." The formula is for this assumption. Need maybe calculate premerger HHI "with percentages as shares" using 0-100. Need show: Pre HHI = 12^2+8^2+25^2+20^2+15^2+10^2+10^2=1658. Post HHI = (12+8)^2 +25^2+20^2+15^2+10^2+10^2 = 1850. Increase = 2*12*8 = 192; or 1850-1658=192. The combined share industrial yarn =20%. Threshold for combined share: "at least 25 percent" not met (20). HHI trigger: post HHI 1850 >1800, but HHI increase 192 not >200, so not met. Structural presumption: not apply (requires both >1800 and >200). Need perhaps mention "other screens may still require investigation" but no filing under industrial. Since transaction >100m and medical may trigger. Need maybe identify "properly defined market" no issue: industrial and medical are separate because no customer substitution; don't combine. Need maybe mention "the HHI increase formula uses premerger shares, not revenues, so for industrial HHI increase = 2×12×8 =192." Need maybe discuss "combined share in medical mesh with verified domestic revenue only" as: Current = 24/80 = 30%. Additional imports I. If I unverified, cannot lower the verified share. For trigger: - If I ≤16: share ≥25 -> filing on share alone. - If 16 share trigger absent, but HHI trigger must be evaluated. At I = 30, share =24/110=21.8%. At I=0, share=30%. At I=16, share=25%. At I=16+ε, share<25. Need maybe use "million" consistently. Need perhaps calculate HHI increase for medical as function of imports? They didn't ask but "HHI cannot yet be calculated reliably" maybe mention delta if no imports? With Q=0, Alder share 22.5%, Prism 7.5%, delta=337.5; post HHI unknown because other sellers not itemized. If Q=16, Alder 18.75, Prism 6.25, delta = 2*18.75*6.25=234.375. If Q=30, delta=2*16.36*5.45=178.5? Let's compute with percentages: A=18/110*100=16.3636, P=6/110*100=5.4545; delta=2*16.3636*5.4545=178.512. At Q=24, D=104, delta=2*(18/104*100)*(6/104*100) =2*17.3077*5.7692=199.704? Need threshold D=103.923 -> Q=23.923. The HHI increase threshold >200 ceases once Q > about 23.9m. Is this useful? The problem asks "Why medical-mesh HHI cannot yet be calculated reliably." Mention: The *increase* can be calculated only if Q and the assumption that the $24m is all Alder/Prism sales are used, but the *postmerger HHI* requires a full share distribution. But the HHI-increase trigger itself can be assessed once Q known. But because post HHI unknown, can't conclude no HHI trigger. Maybe include optional. Need maybe answer "No verified seller-by-seller import shares are available, so reliable HHI cannot yet be calculated" because: - HHI is sum of squares of all individual seller shares. Knowing total qualifying imports and combined Alder/Prism revenue does not reveal how import revenue is split among importers, nor the identities/shares of "other verified sellers." - Different allocations (one large importer vs many small importers) produce very different HHI; "aggregate imports" cannot be assigned to any seller. - HHI increase from merger may also depend on Alder/Prism shares (which are known if Q known), but postmerger HHI threshold depends on market concentration including all competitors. Need seller-by-seller import shares. The existing $56m "other verified sellers combined" lacks individual breakdown too, so even without imports, HHI not calculable from provided data. - Customs codes combine medical mesh with unrelated textile products, so must verify product-level categories to avoid overstating market and understating shares. Need perhaps mention "If imports are verified, all qualifying imports count regardless seller location; no geographic boundaries based on seller location." Need maybe discuss "market definition" no combining products to dilute; industrial and medical separate. Medical mesh combined share remains high under domestic verified data. Need perhaps mention "Filing not concede illegality; if after verification share below threshold, unnecessary filing may be withdrawn? But absent procedure known, cannot give. But rule 8 says a filing does not concede; parties can later argue entry etc." But if filing because threshold met by share, after filing they can present evidence. The "remedy evidence after filing" relevant if structural presumption? Actually if threshold met, they can present entry/expansion/efficiencies/failing firm/remedies. Need mention maybe not central. Need think if "The parties want to sign next week and close in 35 days." If file now but data comes in after 10 days, if data proves no filing, can the filing be withdrawn? Not specified. But "wait for ten-day data work" seems plausible. However under Rule 7 "must obtain it or recommend filing conservatively." If obtainable within ten days, and closing is 35 days, you can obtain. But if signing next week before data, is signing "closing" no. Need maybe recommend "start the 10-day verification immediately. If it is completed before the filing deadline and shows I>16 with no HHI trigger, no filing; otherwise file before closing." But what about "filing now vs wait"? We can say: - Do not sign/close without determining whether filing is required. If closing were today, you must file because current verified share 30%. - The conservative approach is to file now (or at least before close) if management will not wait for verified data. But because the data is obtainable in 10 days and closing is 35 days away, it is permissible/consistent with Rule 7 to wait, but only conditionally: require the specialist to work now; if by the time needed for a pre-close filing (or before signing? no) the verified imports do not exceed $16m or HHI data remains unavailable, file before closing. - Proceed without filing is unacceptable. But "concrete recommendation conditioned on missing market figure" maybe: 1. If verified import revenue > $16m and full seller-by-seller HHI shows postmerger HHI ≤1800 or Δ≤200 (with no share trigger), no filing required. 2. If verified import revenue ≤$16m, file before closing; current share ≥25%. 3. If cannot verify before close or HHI cannot be reliably calculated, file conservatively now/ before close. Maybe mention "If verified import revenue is >$16m but the HHI data remains unavailable, do not assume no filing; the HHI trigger could still be met. File conservatively unless the full HHI can be calculated and falls below thresholds." This is important. Is "HHI data remains unavailable" maybe after 10-day data, if specialist only verifies total not seller-by-seller, then still file? The question says "No verified seller-by-seller import shares are available" at present; but "specialist can verify qualifying import revenue within ten days from customer and importer records." Perhaps after 10 days total import revenue, but not necessarily seller-by-seller. It might be that seller-by-seller import shares could be obtained from customer and importer records too? The "specific data needed" includes seller-by-seller; maybe if verifying total from customer/importer records, one can also identify sellers. Need say "also obtain, not just total, the seller-by-seller breakdown; otherwise the HHI trigger cannot be cleared." Need perhaps decide if "file now" or "wait ten days" should be primary. Let's evaluate the legal rule 7: "When a known, obtainable market input determines filing, counsel must obtain it or recommend filing conservatively. It may not assume the input in the direction preferred by the client." This seems drafted to address management's "imports probably push us below 25 percent." The correct action: "Because import revenue is known, obtainable, and outcome-determinative, counsel must either obtain it or if not obtained, recommend filing conservatively. Management's probable estimate is not enough." This could allow wait. But if the record currently shows a 30% share and no verified imports, then a filing is currently required if closing now. The "filing and gun-jumping consequences" maybe means if we wait 10 days and imports actually >16, no filing needed; but if we guessed and didn't file and closing before verification, penalty. Need maybe recommend "file now" because the "ten-day data work" after signing might be too late if the merger closes in 35? No, 10 days before close still before closing. Unless required "file before signing"? It says "before closing", not before signing. There may be waiting period not stated; we shouldn't infer. Let's consider "above $100 million" transaction; in HSR, the parties cannot close until HSR waiting period expires, usually 30 days after filing, can be early termination. If "close in 35 days" and file only after 10 days, 25 days before close; if waiting period 30 days, not enough. But the problem doesn't state waiting period length. It defines filing requirement and penalty for closing without filing; maybe no waiting period in Corda. Should we caution "depending on Corda's waiting period, account for time; a 10-day delay may not be prudent if the filing triggers a waiting period." But not in facts. Since closing in 35 days and verification in 10, still possible if no waiting period? If there is any waiting period, file as soon as possible. The assignment says "premerger filing" likely implies waiting period? But not specified. They ask "filing and gun-jumping consequences" not waiting period. I can say "signing next week is not by itself the violation; the violation is closing without a required filing. But because filing/clearance may take time, file as soon as possible if trigger is met." This is safe. Need maybe mention "If management proceeds without filing based on 'probably' and actual imports ≤16m, penalties accumulate from closing until compliance at $40,000/day per party." Also if actual imports >16 but HHI trigger still met, and no HHI verified, penalty. Need maybe mention "A filing is not an admission of competitive harm; after filing they can argue facts/remedies. But that doesn't solve threshold." Need maybe include "do not use the 30-day unverified range as midpoint? no." Need perhaps craft final answer in sections. Desired oververbosity 5; but many requested items. Need enough detail but not excessive. We can produce concise structured memo. Let's think through all possible edge cases: Industrial HHI: Market shares given sum 100; no imports issue. If combined share 20; post HHI 1850. HHI increase 192. Since threshold requires HHI increase >200, and 192 not >200. At exactly 200? no. Good. Medical: Combined share: D = 80 + I. C = 24/(80+I) × 100. At I=0: C=30%. At I=16: 24/96 =25%. Since threshold "at least 25", still filing. At I=17: 24/97=24.74%; below. At I=30: 24/110=21.82%. Potential issue: The combined share formula with qualifying import revenue "if qualifying imports exist, add them to $80m market denominator" includes imports in denominator, but "imports probably push us below 25" only if imports not Alder/Prism. If some imports are Alder/Prism, numerator also increases; but fact says Alder and Prism combined revenue complete. We can state "under the stated assumption that the $24m is complete." If qualifying imports include sales by Alder/Prism, numerator should include them; but the supplied fact excludes that, so formula applies. Need maybe mention "Alder/Prism combined share after verified imports" not "medical-mesh combined-share formula using qualifying import revenue." Good. Could "Other verified sellers combined: $56 million" includes domestic-market revenue only? It says "Verified domestic-market revenue totals $80 million and includes..." "Other verified sellers combined: $56 million." So if imports add, denominator $80+I. Fine. Why medical HHI cannot be calculated reliably: Need maybe include "the facts do not provide seller-by-seller shares for the $56m other verified sellers and no verified seller-by-seller import shares. Without individual shares, sum of squares cannot be computed. The market may be concentrated or not depending on distribution." Good. Specific data needed: - "customer and importer records" from specialist: invoices identifying product as medical conductive mesh, delivery destination Corda, dates within measurement year, revenue amounts, seller/importer identity, purchaser identity, no double counting. - "Customs entries under relevant code plus bills of lading and product descriptions to exclude unrelated textile products." - "for HHI: revenue by each seller/importer, not just aggregate, and whether imports were sales into Corda or transshipment/export." Gun-jumping: - "Do not exercise operational control/coordinate before closing; but here legal focus is no closing before required filing. If required and not filed, each party $40k/day from closing until compliance. Also risk of enforcement/investigation. A 'probably' belief is not defense." - "If no filing and data later shows trigger, penalties cannot be avoided by 'curing' until compliance from closing date." Need maybe include "waiting ten days": Let's refine recommendation carefully. Potential final recommendation: "Start the 10-day verification now. Do not rely on management's range or 'probably.' Since the current verified record already shows a 30% combined share, the responsible path is to file before closing. If—and only if—verification is completed promptly and proves both (i) I>16 and (ii) a reliable HHI calculation shows no HHI trigger, then a filing is unnecessary. If I≤16, file before closing. If the HHI cannot be fully verified, file conservatively before closing. Do not proceed without filing." But "file before closing" vs "file now": If file now and then verification proves no filing, maybe unnecessary but okay? Rule 8 says filing does not concede. But premerger filing can have costs/effects; maybe "file now" may be too conservative if data obtainable and closing far. But "current verified record already shows 30% share" maybe "the rule says claimed imports included only to extent verified; so on the present record, the trigger is met." Therefore, if signing next week and closing in 35, must file before closing; the safest is "file promptly." But if data can be verified within 10 days, maybe can wait, but the question "whether to file now, wait for ten-day data work, or proceed without filing" likely expects "obtain data; based on data." Let's determine what final recommendation "conditioned on the missing market figure" means. Maybe they want: - "Wait for the 10-day data work" is permissible if it can be completed before closing, but because the threshold may turn on data, don't proceed without data. If data shows imports over $16m, no share filing, but HHI uncertain; seek seller-by-seller data. If data shows imports under/equal $16m, file. If data unobtainable, file conservatively now." But maybe "file now" is still needed because "current verified record" shows 30%. Let's see exactly: "A premerger filing is required ... when, in any properly defined market, either ... combined share is at least25." At present, without verified imports, combined share in medical mesh 30. Therefore, under current facts, there is already an obligation? The parties want to close in 35 days; if they don't have verified imports at closing, the share is 30. But if they obtain data before closing, the market figure becomes known. Not "at present" necessarily. The phrase "claimed imports are included only to extent verified as sales into relevant market during measurement year" means in determining whether a threshold is met, only verified imports count. It doesn't say you can't verify later before closing. The obligation to file arises if threshold is met at time of closing? It says before closing when threshold is met. If at closing the verified import revenue >16, no share threshold. So maybe waiting is allowed if data done before closing. The "closing in 35 days" makes waiting feasible. But if filing plus waiting period could make close date impossible, wait not advisable. The problem didn't specify waiting period, but maybe "premerger filing" requires before closing and "closing without filing penalties"; no review time. Could answer: "The safest and most defensible action is to file now, not wait." But then, if imports verify >16 and HHI no trigger, filing was not required but not forbidden. Rule 8 says filing does not concede illegality; but unnecessary filings are generally possible? It doesn't say prohibited. In real HSR, you can withdraw a filing if not required? But if no threshold, making a filing may be voluntary but accepted? Maybe. But the assignment asks "file now, wait for data work, or proceed without filing, with concrete recommendation conditioned on missing figure." "File now" might be too blunt because if the missing figure shows no trigger, a voluntary filing could be unnecessary. However "when a known, obtainable market input determines filing" permits conservative filing, but doesn't necessarily prefer. Let's think from a lawyer's perspective: The parties want to sign next week. The transaction is $140m. In medical market, current verified share is 30%. Alder/Prism have complete revenue. Imports are claimed but unverified. Rule: claimed imports included only if verified. Therefore, if you were asked today "is a filing required?" the answer based on verified facts is yes. But the rule 7 says "When a known, obtainable market input determines filing, counsel must obtain it or recommend filing conservatively." It says "or"; if you don't obtain, file. Since you can obtain in 10 days, you can obtain. But if you don't have it before signing, maybe you could still file after signing but before closing. The question "parties want to sign next week and close in 35 days" maybe asks whether to sign and wait data? The penalty is only for closing without filing; signing isn't illegal. But "premerger filing" likely should occur after signing? Usually HSR filing requires signed agreement or letter of intent? But not specified. Need avoid too much. Potential final recommendation with conditional: "Recommendation: Launch verification immediately. Do not make the decision on management's 'probably.' If verification is finished before the filing decision date and shows I>16 and full seller-by-seller HHI can be computed and falls below both HHI triggers, no filing is needed. If verification is not finished, or I≤16, or HHI cannot be computed/cleared, file before closing. Given the current 30% verified share, the conservative default is to file now; management's plan to proceed without filing is not defensible." This should satisfy "file now, wait, or proceed without filing" by saying "conservative default file; can wait only conditionally; proceed without filing never." Need maybe mention "if filing now is chosen, it is not an admission; after filing, can challenge market definition/imports/HHI and present efficiencies/remedies. If no filing after data, no issue." Need perhaps mention "HHI increase in industrial not >200 but post HHI high, so no structural presumption but agencies may investigate; not relevant to filing." Good. Let's formulate final answer. Let's consider if there is any need to address "medical-mesh combined-share formula using qualifying import revenue" with "imports as X million and market denominator" maybe "Claimed imports are included only to extent verified; until verification, X=0 for legal purposes." This is crucial. So: Let V be verified qualifying import revenue. If V = 0 as currently, share=30. If V between 0 and 30: share = 24/(80+V) = 2,400/(80+V) percent? Actually 24/(80+I)*100 = 2400/(80+I)%. Wait yes if share as percent = 24/(80+I)*100 = 2400/(80+I). I previously wrote 24/(D)*100. Equivalent. At I=16 => 2400/96=25. Good. Potential notation: Use I, not Q. At I=16 exactly, share =25%. Need exact threshold "I > 16m." At I=16 no fall below. If the test "at least 25%" means at exactly 25 is a filing trigger, so "below 25 requires I>16." If someone says "$16 million" maybe clarify. Need perhaps calculate "plausible range 0-30 includes the critical 16; management can't infer no filing from range; a wide range contains both outcomes." Need maybe discuss "HHI if imports no seller-by-seller" with "all claimed imports are in the denominator but cannot be assigned to firms. HHI not reliable." Good. Potential optional table: Market | Combined Share | Pre HHI | Post HHI | Δ HHI | Trigger/Presumption Industrial |20% |1658 |1850 |192 | No trigger; no presumption. Medical |24/(80+I)%; currently 30% at I=0; I>16 reduces below25 | Not calculable | Not calculable | Increase calculable but post not | Share trigger unless I>16; HHI unresolved. Need perhaps include "Postmerger HHI" for industrial "combined share=20, but HHI post computed by replacing 12,8 with 20. The HHI increase formula 2×12×8=192; because 1850 >1800 but 192 not >200, HHI trigger not met. If threshold required "more than 200 points", 192 not." Good. Let's think of "structural presumption applies in that market" for industrial: Rule 4 says post HHI above 1800 with increase >200 creates structural presumption. Industrial post HHI 1850 >1800, but increase 192 <200. So no. It may still be an "other screen" requiring investigation? The rule says "Other screens do not create that presumption but may still require investigation." We can mention "agencies could still investigate high concentration, but no filing threshold or structural presumption from this market." Should we mention "postmerger HHI 1850 is high but delta just below safe harbor; no HHI trigger." Good. Need perhaps if the industrial market alone not trigger but medical market does; the fact transaction $140m above $100m globally; if any market triggers, entire transaction filing required. So recommendation based on medical. Need maybe calculate "postmerger HHI medical with no imports" if we can? No, because individual shares of other sellers unknown. But if someone asks "whether either filing trigger or structural presumption applies in that market" maybe for industrial only; "medical-mesh HHI cannot yet be calculated reliably." So okay. Let's examine if "HHI increase" in medical can be computed reliably if no seller-by-seller import shares? Suppose no import seller shares, but Alder and Prism shares known. Increase =2*A*P. A and P maybe known if total medical market verified. Since import total unknown, not known. If import total verified, A/P known. So delta not currently calculable either, unless assume I=0. But the assignment says "No verified seller-by-seller import shares are available, so a reliable medical-mesh HHI cannot yet be calculated." HHI includes delta? They may refer to full HHI. We'll mention "the HHI increase cannot be verified until I is verified; even then, full postmerger HHI cannot be calculated without seller-level data." Should we maybe calculate a "safe harbor" based on Alder+Prism shares and HHI increase if imports max 30: At I=30, combined share=21.8, delta=178.5. The HHI increase not >200; but if qualifying imports are less than ~23.9, delta >200. But post HHI unknown. Is there any way threshold "postmerger HHI exceeds 1,800 and merger increases HHI by >200" could be evaluated using lower bound? Actually if HHI increase >200 but post HHI unknown; if HHI post max? Could be above or below. But maybe with minimum possible HHI, we can know if post HHI cannot exceed? No. At D=80 with only known shares, minimum HHI = A^2+P^2 if residual all infinitesimal = 506+? Let's compute A/P with Q=0: A^2=506.25, P^2=56.25, sum=562.5. Post HHI min pre + delta =562.5+337.5=900 <1800. So cannot know. At D large, min lower. So indeed no. Need perhaps mention "A reliable HHI cannot be calculated because 'other verified sellers combined' is aggregated, and imports have no seller-level verification. HHI could be below or above 1,800 depending on fragmentation. For example, if the other $56m and imports are held by one firm, HHI very high; if fragmented among many, low." Nice but not necessary. Maybe include simple explanation. Need think if "customs codes combine medical mesh with unrelated textile products" has implication for import verification and market definition. The data must be at product level, not aggregate customs code, because using broad customs code would include unrelated products and understate share. Good. Need maybe include "filing recommendation conditioned on missing market figure" in final concise paragraph. Let's craft final response with "Memo" style. Potential final: ``` Industrial conductive yarn - Combined share: 20% - Pre HHI: ... - Post HHI: ... - ΔHHI: ... - Filing trigger: no; structural presumption: no. ``` Then medical: ``` Let I = verified qualifying import revenue ($m). Market size = 80+I. Combined share = 24/(80+I)*100 = 2400/(80+I) %. Currently, with no verified imports, I=0: 30%. At I=16: 25%. Below 25 only if I>16. If I=16, share exactly 25, still trigger. If I=0-16, share >=25. ``` Then HHI: ``` No reliable HHI can be calculated because seller-by-seller shares of other domestic sellers and importers are absent. The $56m combined residual has no individual shares; imports have no verified seller allocation. HHI depends on the distribution, not just total market size. A HHI trigger cannot be ruled out even if total I>16 unless seller-level data confirms. ``` Data needed: ``` Customer/importer records with product-level invoices, delivery to Corda, measurement-year dates, revenue per seller, identities, customs entries excluding non-medical products, and seller-by-seller breakdown to compute HHI. ``` Filing consequences: ``` If required and not filed before closing: $40k/day per party from closing to compliance; possible investigation/remedies; no 'probably' defense. Management's unverified import assumption cannot be used (Rule7). Signing is not necessarily closing but do not close until filing. Do not coordinate before closing. ``` Recommendation: ``` Start verification immediately. - If verified imports >$16m and full seller-by-seller HHI is verified and shows no HHI trigger, no filing required. - If verified imports ≤$16m, file before closing. - If the import revenue cannot be verified before closing, or HHI cannot be reliably calculated, file conservatively before closing. - Do not proceed without filing based on "probably." Given current verified record, conservative default is file now unless/until the condition above established. ``` Need maybe mention "if current verified share 30% and closing is 35 days, file before closing; if you choose to wait 10 days, have a hard deadline to file with sufficient time." Good. Let's consider if "file now" vs "wait" in recommendation: Maybe final line: "Unless the 10-day verification can be completed promptly and establishes BOTH (i) I>16 and (ii) a reliable HHI below the thresholds, I would file now (or at least before closing). Waiting is acceptable only while the verification is actually being obtained and cannot jeopardize the pre-closing filing. Proceeding without filing is not acceptable." This covers. Need maybe include "The ten-day data work will not necessarily end the inquiry because HHI needs seller-by-seller import shares. Have the specialist obtain seller-level detail at the same time." Good. Let's think of any possible legal issue: The rule says "postmerger HHI exceeds 1,800 and merger increases HHI by more than 200 points" for filing. Industrial post HHI 1850 >1800, delta 192. So if there were no medical, no filing. But because HHI increase not >200, no trigger. Good. Potential "HHI increase by twice product of premerger shares" maybe if shares are in percent 12 and 8, delta=192. Premerger HHI 1658, post 1850. Good. Potential "combined share at least 25 percent" if combined share exactly 25? We included. Potential "properly defined market" "customers do not substitute one for the other" means separate markets; we shouldn't combine to reduce share. Good. Potential "Revenue from products delivered into market counts regardless seller location" means imported sales count if verified; if not verified, they don't. Good. Potential "claimed imports included only to extent verified as sales into relevant market during measurement year" Could also mean if imports are "claimed" but not verified, the verified domestic market is $80m; share 30. The rule 7 says not assume input preferred by client. Need emphasize. Potential "customs codes combine medical mesh with unrelated textile products" The specialist should not use aggregate customs data as "imports"; must use product-level invoices/records. Good. Potential "filing and gun-jumping consequences" maybe include "Parties must file before closing when threshold met. If not, each party exposed to $40,000 per day from closing until compliance. If there are two parties, aggregate exposure may be $80,000/day? The statute says "each party" so aggregate. But maybe "each party" means each is liable for $40k. We can say "each party separately, so up to $80,000/day total" but not 100%? Let's parse "exposes each party to $40,000 per day from closing until compliance." It could mean each party (Alder and Prism) is exposed to a penalty of $40,000 per day; total $80,000. To avoid misstatement, say "Alder and Prism may each face $40,000 per day." Good. Potential "not assume input in direction preferred by client" Maybe a direct quote in final: "Management's 'probably' is exactly the kind of assumption Rule 7 forbids." Good. Potential "filing does not concede illegality" Include maybe "If filing is made, it does not concede illegality; parties can present entry, efficiency, remedy evidence later." This addresses management reluctance. Need perhaps include "If no filing because imports >16 but HHI unknown, structural presumption might apply if post HHI >1800 and delta >200; no reliable calculation. Don't assume no presumption." Let's maybe include "HHI increase for medical as a function of I" optional: "Once I is known, the merger's HHI increase would be 2*(18/(80+I)*100)*(6/(80+I)*100) = 2,160,000/(80+I)^2, if no Alder/Prism import revenues beyond the $24m. At I=16, that is about 234.4; at I=30, about 178.5. But this is only the delta; the postmerger HHI also needs the full share distribution." This is extra but useful. But the question says "HHI cannot yet be calculated reliably"; including delta formula might be okay. Desired oververbosity 5; avoid too much. Let's think if "medical-mesh combined-share formula using qualifying import revenue" should include "market denominator = $80m + imports" but what about "Alder and Prism's $24m combined revenue is complete" means if imports are added to denominator, the combined share decreases because numerator constant. This assumes A/P don't have any qualifying imports not in $24m. The exact threshold "I>16" no issue. Could there be another threshold if combined share below25 but HHI trigger? With Q >16 and maybe Q ≤23.9, Δ>200; if post HHI >1800, trigger. Need data. Let's include. Potential "structural presumption" in medical: If after data, post HHI >1800 and delta >200, structural presumption. But currently cannot know. If share trigger already, filing required; if HHI trigger absent, no presumption. But medical share trigger enough. Let's maybe craft final answer: ``` To: Management Re: Merger screen for Alder Loom/Prism Thread Industrial yarn: ... No filing trigger from this market. Medical mesh: Let I = verified import revenue (M). Combined share = 24/(80+I) × 100. Current record I=0: 30%. Threshold: 24/(80+I)=0.25 => 80+I=96 => I=16. At I=16, share=25%, still "at least 25"; only I>16 reduces below 25. ``` Then HHI. Need perhaps say "The $140m transaction clears size threshold. Thus any market trigger requires filing." Good. Need perhaps mention "At I=16, the exact combined share = 25; because rule says at least 25, it is not a safe harbor. At I >16, share <25." Good. Potential "other verified sellers combined" HHI: "Even if I=0, no reliable HHI can be calculated because we lack individual shares of the other $56m. The facts only give aggregate." Wait is that true? If no imports, Alder share 22.5, Prism 7.5, Other combined 70. We cannot know HHI; but maybe if other sellers combined maybe we can get lower/upper? But no exact. Good. Need maybe maybe "If the specialist can document each imported seller's revenue, and we already have other verified seller data, then HHI can be calculated." Good. Let's think of "known, obtainable market input determines filing" and "may not assume input preferred by client" maybe "The 'probable' range is not a verified market input. Rule 7 says if it determines filing, must obtain it or file conservatively. Because a specialist can verify in 10 days, instruct them now. If management refuses, file now." Good. Potential "file now before signing?" Could say "There is no need to sign before filing; if a filing is required, it should be made before closing, and if the current verified data remains unchanged, it is already required. I would not let signing/close occur without either verified no-threshold data or a filing. In practical terms, start the data work today; if the data isn't available by a deadline that still allows a pre-close filing, file immediately." This is robust. Need maybe include "No filing now but wait for data work" recommendation? Let's decide final phrasing: "Recommendation: Start the verification immediately. Do not proceed without filing. If management insists on certainty at signing, file conservatively now. If the verification is finished and proves I>16 and the HHI is below/does not trigger, the filing can be shown unnecessary; if not, file before closing. Because the current verified share is 30%, waiting is safe only as an active verification effort with a firm deadline, not a passive delay." This might be a bit nuanced. But assignment "with a concrete recommendation conditioned on the missing market figure" perhaps expects a decision tree. We can present decision tree. Let's include in final: ``` Decision tree: - I verified > $16m AND full seller-by-seller HHI verified and no HHI trigger -> no filing. - I verified ≤ $16m -> file before closing. - I cannot be verified in time, or HHI cannot be computed -> file conservatively before closing. ``` At end: "Management's 'probably' does not satisfy any branch." Need maybe include "If I verified >$16m but HHI not calculable, should file conservatively because second trigger could still be met. The fact combined share below25 doesn't by itself clear the HHI trigger." This is important. Let's maybe mention "At I > $23.9m, delta <200; but post HHI still unknown. At I between 16 and23.9, delta >200, so HHI trigger can be met if post HHI >1800; this requires data. At I over23.9, delta not >200, but HHI threshold also requires delta>200, so if delta<200 no HHI trigger; however share below25? If I >23.9, share ~22.7; no share trigger; so no trigger? Wait! If I >23.9, HHI increase <200, so the second trigger cannot be met regardless of post HHI. That is useful. But if I ≤23.9, delta >200; post HHI unknown. We can mention "The HHI increase could be >200 until import revenue reaches about $23.9m, so the HHI trigger cannot be excluded without seller-level data." But is it necessary? It demonstrates nuance. Let's calculate threshold exactly: Delta = 2,160,000/(80+I)^2. Set >200: 2,160,000 > 200(80+I)^2 => 10,800 > (80+I)^2 => sqrt(10800)=? 103.923. So I > 23.923 delta <200. For I=23, D=103, delta=2,160,000/10609=203.6. For I=24, D=104, delta=199.7. So approximate $23.9m. Could include as "not necessary for decision; full HHI still missing." But if I >23.9, no HHI trigger because delta not >200. But if I ≤16, share trigger. So the interesting no-filing region requires I >23.9? Wait if I >23.9, HHI increase <200; with I >16 also share below25. So no trigger regardless of post HHI? Let's check: HHI trigger requires both post HHI >1800 and delta >200. If delta ≤200, no. Combined share <25 if I>16. Thus for I >$23.9m, no filing threshold in medical market, assuming no other triggers. But if I between 16 and23.9, share <25 but delta>200; post HHI could exceed 1800 so filing might be required. So even if total imports verified >16 but not >23.9, need HHI. But because Q range 0-30 includes values >23.9. Interesting. Could mention maybe. Can we calculate when post HHI possibly >1800? For market with a huge residual, if imports fragmented, not. Need seller-level. But if delta ≤200, HHI trigger no. The "post HHI >1800" plus delta>200. Need both. If delta <=200, no trigger irrespective of HHI. Rule says "postmerger HHI exceeds 1,800 and the merger increases HHI by more than 200 points." Yes both. So if I≥23.923, no HHI trigger. But wait if delta=200 exactly, "more than" fails. Good. Could the share trigger be "combined share at least25" when I=16 exactly; if I>16 no. So if I>23.923, no filing trigger in medical. But the problem says HHI cannot be calculated; however HHI increase can be calculated, so from I we can eliminate HHI trigger if I>23.9. If I between 16 and23.9, HHI increase enough, but post HHI unknown. Maybe if the remaining market is extremely fragmented, post HHI below1800; but need data. Could we compute maximum possible HHI increase and post HHI lower bound to know if post never >1800? No. Need actual. Should we include this "I>23.9" as part of recommendation? The assignment asks "exact import-revenue level at which combined share falls below 25 percent" not HHI increase threshold, but "medical-mesh HHI cannot yet be calculated reliably." Maybe including delta threshold could be helpful but perhaps overcomplicates. Desired oververbosity 5; maybe include a note: "The HHI increase is not currently verifiable because I is unknown; once I is known, if I is about $23.9m or more the delta is not >200, but the full HHI still matters for the postmerger HHI test." But if delta≤200, post HHI doesn't matter for trigger. Hmm. Let's revisit "Why medical-mesh HHI cannot yet be calculated reliably." They may be testing that a reliable HHI can't be calculated because no seller-by-seller import shares. They may not expect HHI delta threshold. But I can mention in one sentence. Potential issue: "Alder and Prism's $24 million combined medical-mesh revenue is complete." Does that imply Alder share 18, Prism 6; but if imports are additional, denominator includes imports. If Q total verified but no seller-by-seller, total "other" is $56m+Q. HHI "increase" can still be calculated because Alder and Prism shares known. The question "No verified seller-by-seller import shares are available, so a reliable medical-mesh HHI cannot yet be calculated." Maybe "HHI" includes "postmerger HHI", not "increase." Good. Let's think if "HHI increasing by twice product of premerger shares" rule 2: For medical if shares not known? Once D known, A/P shares known; increase known. But HHI base not. The trigger includes post HHI >1800; if base unknown. Good. Need maybe include "The structural presumption in rule 4 applies only if postmerger HHI >1800 and increase >200; because reliable HHI unavailable, no structural presumption can currently be found in medical mesh. But a filing may still be required by share trigger." Good. Potential "if filing required due to 30% share, the structural presumption maybe not necessary." Good. Let's maybe structure final with bullet headings. Need be mindful final answer should not be too long but complete. Desired oververbosity 5, perhaps 1000-1500 words. We can provide around 1200 words. The user asked detailed analysis; okay. Let's formulate final now in my head: ``` Analysis Size test: $140m > $100m. Industrial conductive yarn ... ``` Medical: ``` Let I = verified qualifying import revenue in measurement year ($m). Verified domestic revenue =80; added imports=I; total market=80+I. Combined revenue=24. Combined share = 24/(80+I)*100 = 2400/(80+I)%. No verified imports => I=0 => 30%. Set 24/(80+I) =0.25 => I=16. At I=16, share=25; "at least 25" trigger still. So share <25 only when I>16. If I≤16, share trigger. ``` Need maybe "if Alder/Prism revenue includes imports, numerator complete; if additional A/P imports beyond 24m not included, formula changes." HHI: ``` Industrial HHI no issue. For medical: - Missing import seller shares. - Existing $56m other sellers only aggregate. - Therefore cannot compute sum of squared shares. - Total import revenue alone not enough. Different distributions produce very different HHI. - The HHI merger increase can be calculated once I is known (2*(18/(80+I)*100)*(6/(80+I)*100)), but the postmerger HHI cannot. ``` Maybe include "If I is large enough that the increase ≤200, HHI trigger cannot be met on the increase prong regardless of concentration. That occurs around I ≥23.9m. But that is not a substitute for verification; and if I is less than that, need full HHI." Should I include? It is a useful nuance but might distract. Let's decide. The assignment asks "exact import-revenue level at which combined share falls below 25 percent," not delta threshold. If I mention delta threshold, need not be too prominent. Maybe "For completeness, HHI increase would be >200 only until I≈23.9m; but post-HHI cannot be calculated." This demonstrates understanding. But maybe if I>23.9, no HHI trigger, and because I>16 share below25, no filing. Then recommendation could be more nuanced: if verified I >23.9, no filing? Wait if I>23.9 and share below25, delta<=200, so both filing triggers absent. But what about "post HHI HHI >1800" is one prong and "increase >200" another; if increase <=200 no trigger. Yes. So if I>23.9, no need for HHI to determine no filing. But "reliable HHI cannot be calculated" maybe if delta <=200, HHI not needed for trigger. However structural presumption also needs delta>200, so none. But Rule7 maybe "known obtainable input" if no filing can be established without HHI in that branch; but still need verify I exactly. If I between16 and23.9, HHI data needed. If I≤16, share trigger. If I>23.9, no trigger. Interesting decision: - I≤16: file - 161800; if not calculable, file conservatively. - I>23.9: no share, no HHI increase, so no filing threshold (assuming no other markets); maybe no filing required. But wait what if I=20 and residual highly concentrated; post HHI >1800, delta >200, filing. If residual fragmented, no. So data. Would the structural presumption in medical be possible if I=20? Post HHI could >1800; HHI increase =? D=100, A=18, P=6, delta=216. If post HHI >1800, structural presumption. Need seller data. Should include this HHI-increase threshold? It might be beyond requested but helpful. The problem says "No verified seller-by-seller import shares are available, so reliable HHI cannot yet be calculated." If I>23.9, no need HHI. But the "missing market figure" likely only total import revenue, not seller-by-seller. The 10-day data work can verify total imports. The assignment asks "concrete recommendation conditioned on missing market figure" singular "missing market figure" maybe total import revenue. They may expect: - if import revenue >16, no share trigger; but if less, file. But because HHI unavailable, perhaps if import revenue >16? Wait HHI trigger unknown; perhaps they don't want overcomplicate? But they did ask why HHI cannot be calculated. Hmm. Let's re-evaluate the purpose: They ask "No verified seller-by-seller import shares are available, so a reliable medical-mesh HHI cannot yet be calculated." This means even if total imports known, HHI not. But for filing, if total imports >16, share trigger absent, but HHI trigger unresolved. So a complete recommendation cannot say "if imports >16 no filing." Need say "unless you can also satisfy HHI." The problem asks "exact import-revenue level at which combined share falls below 25%" but "HHI cannot be calculated" to prevent concluding no filing purely due to share. Nice. Potential "HHI increase can be calculated once total imports known" maybe because the HHI trigger's second prong can be assessed. If imports are high enough, delta small; but if not, need HHI. This nuance may be useful. Let's compute HHI increase threshold more exactly: Delta = 2*(1800/D)*(600/D) = 2,160,000/D^2, where D=80+I. Need >200 (strict). Solve D^2 < 10,800. D < 103.923. I < 23.923. Thus "HHI increase would exceed 200 only if I < about 23.9m." If I ≥23.923, no HHI trigger due to increase prong. But if I >16, share also below25, so no filing. If I exactly 23.923, delta =200 not more, so no trigger. But with unverified data no exact. Could there be "postmerger HHI >1800 and increase >200" if delta <=200? no. So if I>=23.923, no HHI trigger. That's a strong condition. But "HHI cannot be calculated" is irrelevant in that branch. But if I between 16 and23.9, HHI data essential. If I<=16, share trigger. Thus a decision tree can be more nuanced. But is HHI increase formula "2*(18/(80+I)*100)*(6/(80+I)*100)" valid if imports are by "other sellers" only? Yes, under assumption A/P combined revenue complete and no A/P imports outside. If A/P revenue includes all their imports, numerator remains 24. Additional imports by others, denominator only. Good. Maybe include this in a "Not for triggering conclusion" note: "Once I is known, the HHI increase would be ... At I≈23.9m or higher the increase no longer exceeds 200. But if I is less, the postmerger HHI must be known; it cannot be inferred from aggregate imports." Would including this confuse the "exact import level at which combined share falls below25"? Maybe no, but perhaps final answer should prioritize. Let's think of "filing trigger" in medical: Combined share with no imports: 30% -> already required. If management wants no filing, must establish I>16. But if I=20, share below25 but HHI trigger could be possible. The phrase "medical-mesh HHI cannot yet be calculated reliably" means "cannot yet conclude no HHI trigger." However if I=20, delta=216, so HHI trigger possible. If I=30, delta=178, so no HHI trigger. Since range up to30, actual I might make HHI moot. The "specific data needed to verify imports" should include seller-level for HHI if I not high enough. Good. Maybe final recommendation: ``` Have the specialist gather both total qualifying imports and seller-by-seller revenue. Until then: - If verified I≤$16m: file. - If verified I>$16m but I<$23.9m: need full HHI; if HHI cannot be computed before closing, file conservatively. - If verified I≥$23.9m: share<25 and ΔHHI≤200, so no trigger on the known medical market; (assuming no other trigger) no filing. ``` But wait, if I between16 and23.9 and post HHI >1800? Need data. If HHI cannot calculate, file conservatively. If I≥23.9, no HHI trigger because delta≤200; no share. This is a concrete condition on missing figure. But the question said "No verified seller-by-seller import shares available, so reliable HHI cannot yet be calculated." It didn't ask to calculate delta threshold. However this threshold is from known HHI increase formula and could be relevant. Should I include? It may be seen as extra. It doesn't hurt if clear. But is it correct that at I exactly 23.923, delta = 200 exactly? Let's calculate: D=80+23.923=103.923. D^2=10800. Delta=2,160,000/10,800=200. Since "more than 200", at exact no. If I slightly below, >200. We don't have exact decimals from facts. We can say "about $23.9m (where the increase falls to 200)". Need maybe if I>16 and I<23.9, share<25 but HHI increase >200; post HHI could be? If post HHI unknown. But if the "other verified sellers combined" is $56m and imports I less than 23.9, total other revenue D-24 maybe between72 and95.9. It could be concentrated or fragmented. Need data. If I >23.9, no HHI trigger due to delta; but what about "postmerger HHI exceeds 1800 and merger increases HHI by more than 200 points" yes both conjuncts; no. However, the "Rule 7 known obtainable market input determines filing, must obtain it or recommend filing conservatively" If total imported revenue I can be verified within 10 days; the HHI seller-level may not be available within 10 days. If I turns out high enough to moot HHI, no need seller-level. But if I not high enough, maybe need more. Since problem says specialist can verify qualifying import revenue within ten days from customer and importer records, maybe seller-level will be available from same records? We can say "ask for seller-level detail in the same records." Need maybe include "If no verified imports after 10 days, treat I=0 for legal purposes and file; do not count 'reported but unverified' imports." Good. Let's think of "claimed imports included only to extent verified as sales into relevant market during measurement year." If after 10 days specialist verifies total imports but not seller-by-seller, can we rely on total imports for denominator? Rule says only to extent verified. If total import revenue verified, count in denominator; if seller allocations not verified, maybe total can count as "other sellers" only if verified that the sellers are not Alder/Prism? They have customer/importer records, so likely yes. Need mention "verification must include the seller/importer identity; otherwise cannot know whether the import revenue belongs to Alder/Prism or other firms." Good. Potential "customs codes combine medical mesh with unrelated textile products" means "customs data alone overstates imports, which would understate Alder/Prism share and HHI; need product-level documentation." Good. Potential "closing without required filing exposes each party to $40,000 per day from closing until compliance" Should maybe say "if closing without required filing, each day from closing until compliance. If eventually file after closing, penalties accrued but stop upon compliance." Good. Potential "file before closing" maybe if management sign next week and close in 35, they could file after data. But if rule requires "premerger filing" and perhaps waiting period, need add "with enough time before scheduled closing." Good. Let's maybe include "It is not enough to file on the closing day; file before closing and allow any applicable review/waiting period." The prompt doesn't specify waiting period but says premerger filing. We can say "and any required waiting period" if not too much. But rule not mention; maybe avoid inventing. Yet "premerger filing" usually before closing; if no waiting period, "file before closing" enough. Need maybe include "If threshold not met, no filing required, but this conclusion must be documented with verified data." Good. Let's prepare final. Potential final text: ``` Assumptions: transaction size $140m > $100m; market definitions separate; no cross-market aggregation. Industrial... ``` Let's calculate industrial HHI again with "premerger HHI" "postmerger HHI" perhaps exact: Pre: 12²=144, 8²=64, 25²=625, 20²=400, 15²=225, 10²=100, 10²=100. Sum 1658. Post: (20)²=400 +625+400+225+100+100=1850. Delta = 1850-1658=192 =2*12*8. Combined share=20%. No trigger: 20<25; post HHI >1800 yes but delta not >200. No structural presumption. Medical: At I=0, combined share 30. Threshold: 24/(80+I)=25/100 -> 80+I=96 -> I=16. If I=16 share 25; because "at least 25" still trigger. To be below 25, I>16. At I=30, share 21.8. HHI: No reliable HHI. If I known, HHI increase: A=18/(80+I)*100, P=6/(80+I)*100; Δ=2AP. But aggregate other shares missing; post HHI cannot. Existing $56m "other verified sellers combined" is aggregate. Also imports seller-level missing. So cannot determine if post HHI>1800. Need seller-by-seller. Data needed... Filing/gun-jumping... Recommendation... ``` Let's decide on including HHI delta threshold in recommendation. Maybe in recommendation: "Because the HHI increase, once I is known, is 2×A×P, if I is about $23.9m or more the increase is 200 or less; that would dispose of the HHI trigger. But if I is below that, the full seller-level HHI is necessary. Since the specialist can get records in 10 days, ask for seller-level detail so this can be resolved." This is too detailed? It could be useful. But the "specific data needed to verify imports" includes "seller-level import shares" so okay. Let's think if "HHI increase >200" threshold with I between16 and23.9 might require no filing if post HHI <=1800. But if post HHI can't be calculated, conservative filing. This decision tree is more complete. Could there be "postmerger HHI cannot exceed?" Maybe if HHI increase >200 and post HHI unknown. But perhaps because total market size and combined shares, maximum HHI might be high; not relevant. We cannot rule out. Let's consider if "other verified sellers combined $56m" are "other verified sellers" with individual shares perhaps not needed for "combined share" but needed for HHI. The HHI trigger in medical if no imports and no seller-by-seller other data cannot be determined. But share trigger at 30 does filing. If imports >16 and below 23.9, share absent; if post HHI cannot be known, maybe no filing if government cannot calculate? No, counsel must not assume; file conservatively. Potential "structural presumption" in medical if post HHI cannot be calculated; no presumption but filing may still be required? We can say "No structural presumption can be assessed now; the share trigger is sufficient unless imports verified >16 and HHI cleared." Good. Let's maybe include "Filing now is not a concession" after recommendation: "Rule 8 means filing now would not prejudice the merits. If later verification shows no threshold, that evidence can be presented; if the share/HHI thresholds are met, the parties can still present entry/efficiencies/remedies after filing." Good. Potential "management argues imports probably push us below 25" maybe response: "The probable range is not verified; rule 3 and 7 prohibit relying on probable unverified imports in the client's favor. The high end of range is30 and low end0; both possible. Management's argument treats the midpoint or maximum as fact. Not acceptable." Good. We'll include. Let's perhaps answer as if giving a memo: - "Signing next week doesn't cure; but filing can be made after signing if before closing. But because current verified share is30, I would not let the 10-day verification run without a hard fallback." Good. Let's write final response elegantly. Potential final final: ``` Alder Loom / Prism Thread Merger screen Size test: $140m > $100m. 1. Industrial conductive yarn ... ``` Need avoid saying "postmerger HHI above 1800 but increase 192, no structural presumption" but "other screens may still require investigation" optional. Then "Medical conductive mesh" Need "Combined share formula using qualifying import revenue" with "I" "verified" maybe. At I=0, current record: 30; if I=16 exactly, 25; below if >16. What about "If verified imports = 0, HHI cannot be calculated" maybe okay. Specific data: "customer and importer records" "product-level invoices" "customs entries" "delivery to Corda" "measurement year" "revenue per seller/importer" "not aggregate customs code" "not transshipments" "breakdown of all sellers to compute HHI." Filing and gun-jumping: "Required filing must occur before closing if threshold met. If closing without filing, each party $40k per day. The belief imports 'probably' exist is not defense. If Alder/Prism coordinate or exchange competitively sensitive info preclosing, separate gun-jumping risk; do not operate as merged before closing." Recommendation: "Start the verification immediately, but conservative default is to file now if data not available. Do not proceed without filing. If you want conditional: - Verified imports ≤16: file. - Verified imports >16 but HHI increase/relevant HHI not cleared: file unless full seller-level HHI shows no trigger. - If verified imports ≥23.9: share below25 and HHI increase≤200, no share/HHI trigger; HHI data not needed. But this must be verified before closing." Need be careful "≥23.9" exact? Since if I>approx 23.9, share below25 and delta≤200. Good. If I exactly threshold, delta=200 not >. We can phrase "about $23.9m or more." Maybe the problem didn't ask for delta threshold; including in recommendation may be too much but okay. Need not overcomplicate primary recommendation: - "If I >16 and no HHI trigger can be verified, file conservatively" is enough. But to be "concrete recommendation conditioned on missing market figure," I can say: "Conditional on the missing figure: * I≤16: file. * I>16 but HHI remains unverified: file conservatively unless/until HHI is verified and clears. * I verified at a level where ΔHHI≤200 (~23.9+) and I>16: no filing based on this market. This might be the most exact, but need ensure "HHI remains unverified" not if I high. Let's include the approximate threshold as a sub-conditional to show expertise. Let's verify the HHI delta threshold formula maybe if D=103.923, shares: A=18/103.923*100=17.32, P=6/103.923*100=5.77, product=99.96, times2=199.9. Good. At I=23.9 total market 103.9. Combined share=24/103.9=23.1 (<25). HHI post maybe could be high. But delta=200, not >. So no trigger. Need maybe "if I > $23.9m, HHI increase is not >200, so the HHI trigger is not met; because then I >16, share trigger not met." Hmm if rule "postmerger HHI exceeds 1800 and merger increases HHI by more than 200 points" yes. Good. But if HHI increase≤200, structural presumption cannot apply, but "other screens may still require investigation" optional. No filing. Potential issue: The HHI increase threshold uses premerger shares based on including imports in denominator. If I >23.9, Alder share and Prism share are lower; yes. But if imports verified as additional denominator and no A/P imports, okay. If some imports by Alder/Prism, numerator changes; but fact says combined revenue complete. Good. Let's maybe not state "if I≥23.9 no filing" unconditionally, because if Alder/Prism have additional imports not in $24m or if another market? But under assumptions, no. We can say "in this medical market." Good. Need perhaps include "If I=16 exactly, share=25; the phrase below25 not satisfied. If I=16.1, share=24.94; no share trigger. But HHI trigger may remain." Good. Potential "other verified sellers combined" maybe if I >23.9 no filing, HHI not needed. But if HHI increase ≤200, no structural presumption but "other screens may still require investigation" not filing. Good. Let's think if "claim imports included only to extent verified" means unverified imports should be treated as zero, not "plausible range." Thus if the specialist doesn't complete, I=0 for legal decision, and filing required. We'll say. Need maybe "file now or wait?" Let's craft recommendation in final: ``` I would not wait passively. Because verification is obtainable before closing, the correct first step is to launch the 10-day review now and instruct the specialist to obtain seller-level detail. My default, if any doubt remains when the filing decision is made, is to file before closing. If the review definitively shows the no-trigger condition, no filing is needed. Proceeding without filing on "probably" is not acceptable. ``` This answers all. Let's also mention "If you sign next week before verification, signing is not itself the violation (assuming no coordination); but close before filing after threshold is the violation. If the data is not back by a date that still permits a pre-close filing, file first." This is nuanced. Maybe include in recommendation: "Signing next week is permissible without a filing if no threshold has been confirmed, but do not close without resolving the trigger. The safer course is to complete verification before signing or file before closing." Hmm "permissible" could be too definitive if law says "premerger filing required when threshold met" not "before signing"; okay. But if current record already shows 30%, threshold is met now; "signing next week without filing" might be permitted because filing before closing, not signing. But to avoid legal advice beyond facts, say "The statute requires filing before closing, not necessarily before signing; but if verification is not obtained, do not let signing/close happen without filing." Good. Potential "filing now" with current 30%: If they file now, and later data shows no threshold, can they withdraw? Not specified. But no concession. Good. Let's now formulate final answer in full. Use "percent share" notation. Let's prepare final message. Double-check formulas: Industrial HHI: Pre = 1658. Post = 1850. Δ=192. Combined 20. Threshold: - (a) at least 25: no. - (b) post >1800 and Δ >200: post yes but Δ no. Structural presumption: - same, no. Other screens maybe. Medical: Let I = verified imports in $M. Market = 80+I. Combined revenue = 24. Share = 24/(80+I)*100. Current =30. At I=16:25. "Below25" if I>16. Because "at least 25" if I=16. HHI: - If I =0, shares: A=22.5, P=7.5, others aggregate70. HHI not calculable. If other share fragmented, HHI maybe lower; if concentrated, high. - Need seller by seller. Additional imports: if one importer has large share, HHI high; if fragmented, lower. - HHI increase formula once I known = 2*(18/(80+I)*100)*(6/(80+I)*100). If I about23.9+, increase≤200; but if lower, need post HHI. Data needed: - Product-level proof. - Delivery into Corda in measurement year. - Revenue per seller/importer. - Customer/importer identity. - Customs docs, invoices. Exclude unrelated products. Filing/gun-jumping: - File before closing if required. $40k/day per party. Both. - Management "probably" not enough; Rule7. - Filing not admission. Recommendation: "Start verification. If no verified data by deadline, file. If verified no-trigger, no file. If in doubt, file." Good. Potential perhaps "The transaction size above $100m is satisfied, so only market-specific triggers; if either market triggers, filing required." At end maybe "Because medical mesh currently triggers, the transaction needs a filing unless the import review changes the analysis." Let's decide if "structural presumption applies in industrial" maybe "No. Although post HHI 1850 is high, the increase is only 192; the structural presumption requires >200. The rule says 'more than 200', so 192 is outside." Good. Potential "Combined share at least 25%" maybe if exactly? In industrial no. Potential "HHI increase formula by twice product" in industrial: 2*12%*8% =1.92? Wait hold on! Important: HHI is sum of squared market shares expressed as whole numbers (e.g., 12^2=144). The formula "twice product of their premerger shares" using percentage points: 2 × 12 × 8 = 192. Good. But if using shares as decimals, HHI =10,000? The problem likely uses percentages; we have 192. Good. Potential "Premerger HHI 1658" if using share percentages 0-100. Good. Let's ensure "post HHI" industrial if Alder+Prism combined 20 and Competitor A 25, B20, C15, D10, E10: 400+625+400+225+100+100=1850. Yes. Need perhaps "The industrial and medical markets cannot be combined to dilute share under Rule 5." Mention maybe: "The two products are separate; combining them would be improper. I analyze filing based on either market; since medical trigger exists, no need to aggregate." Good. Let's write final answer with sections. Potential final wording: ``` A "reliable" medical HHI cannot currently be calculated even with a verified total import figure unless total imports exceed about $23.9m and make the HHI increase prong moot. If it does not, need seller-level shares. ``` Let's decide whether to include this threshold in the main HHI section. Maybe yes: "Once I is known, the HHI *increase* can be calculated: Δ=... It exceeds 200 only while I< about $23.9m. But the postmerger HHI threshold requires sum of squared shares of all firms; with only aggregate other-seller/import revenue, that sum is unknown. If I is below about $23.9m, a full HHI calculation is required." This is helpful. But if I >23.9, HHI increase≤200, so no HHI trigger; however if I was 20, I might need HHI; if I=30 no. Good. Maybe "No verified seller-by-seller import shares are available" could mean "HHI cannot be calculated" and "even the HHI increase cannot be calculated until total imports verified." But once total imports verified, increase can. Let's phrase carefully: "The increase cannot be calculated until total I is verified; the postmerger HHI cannot be calculated until the seller-level distribution of imports (and the residual $56m) is verified." Actually if total I unverified, increase unknown. Good. But "No verified seller-by-seller import shares" maybe not "no verified total" because specialist can verify total in 10 days. Right. Need perhaps "HHI cannot be reliably calculated because imports are not allocated seller-by-seller, and the existing $56m residual is not allocated. Even if total I is known, the HHI sum depends on concentration among importers, not just aggregate." Good. Let's also perhaps state "Current medical filing trigger: Combined share =30%, which is ≥25. Therefore, on the present record, the transaction is already over the share threshold. Additional imports can only change this if verified; they cannot be assumed. Thus if the parties intend to close before verification, they must file." Good. Potential "the specialist can verify within 10 days from customer and importer records" maybe if signing next week, data could be after signing but before close. Fine. Let's now formulate final answer. Need maybe avoid "I" for Alder? Use "Q" to avoid confusion with importer? Maybe use "I" as import. okay. Potential final final text: ``` If I = verified import revenue: Combined share = 24/(80+I) * 100 = 2400/(80+I)%. At I=0: 30%; at I=16: exactly 25%; at I=30: 21.8%. ... ``` Maybe "at I=16 exactly 25% and still a triggering share. Thus the exact point at which the share ceases to be at least 25 is any verified import revenue above $16 million; at $16 million it is not below." Good. Need perhaps "If qualifying imports are exactly $16m, share=25; because threshold is at least25, it is still a filing trigger. This is a common trap." Good. Let's final. Potential final answer length ~1500 words. Good. Let's write final answer now.